Basics Tango Therapeutics, Inc. IPO Date: September 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $161.08M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.67% Avg Daily Range (30 D): $0.08 | 5.38% Avg Daily Range (90 D): $0.09 | 4.34% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .69M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 122 Institutional Trades Total Inst.Trades: 519 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $.73M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $1.6M Avg Closing Volume: 196.57K         News Apr 9, 2025 @ 9:00 AM Barbara Weber, M.D., Elected to ITM Supervisory Bo... Source: N/A Jun 14, 2024 @ 9:10 AM Tango Therapeutics (TNGX) Moves 10.3% Higher: Will... Source: Zacks Equity Research May 24, 2024 @ 3:01 PM Forecasting The Future: 4 Analyst Projections For ... Source: Benzinga Insights May 8, 2024 @ 12:10 PM Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, M... Source: Zacks Equity Research May 7, 2024 @ 2:00 PM Will Tango Therapeutics, Inc. (TNGX) Report Negati... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.19 $-.34 $-1.19 Diluted EPS $-1.19 $-.34 $-1.19 Revenue $ 42.07M $ 4.12M $ 42.07M Gross Profit $ $ $ Net Income / Loss $ -130.3M $ -37.67M $ -130.3M Operating Income / Loss $ -145.6M $ -40.91M $ -145.6M Cost of Revenue $ $ $ Net Cash Flow $ 2.29M $ 16.38M $ 2.29M PE Ratio